Perspectives in MicroRNA Therapeutics - The authors provide insight into microRNA biology, and the simplicity of anti-miR oligonucleotide drug delivery, which can restore balance and function to dysre

ADVERTISEMENT

Perspectives in MicroRNA Therapeutics
The authors provide insight into microRNA biology, and the simplicity of anti-miR oligonucleotide drug delivery, which can restore balance and function to dysregulated microRNA pathways of gene expression.


BioPharm International
Volume 24, Issue 10, pp. 49-53

REFERENCES

1. S.T. Crooke et al., "Mechanisms of Antisense Drug Action, an Introduction," in Antisense Drug Technology: Principles, Strategies, and Applications, S.T. Crooke, Ed. (CRC Press, Boca Raton, 2007), pp. 3–47.

2. S.M. Elbashir et al., Nature 411 (6386), 494–498 (2001).

3. A. Jackson and P.S. Linsley, Discovery Medicine 9 (47), 311–318 (2010).

4. J. Krutzfeldt et al., Nature 438 (7068), 685–689 (2005).

5. D.P. Bartel, Cell 116 (2), 281–297 (2004).

6. E.C. Lai, Nat. Rev. Genet 30 (4), 363–364 (2002).

7. T. Thum et al., Nature 456 (7224), 980–984 (2008).

8. L. Ma et al., Nature 28 (4), 341–347 (2010).

9. R.E. Lanford et al., Science 327 (5962), 198–201 (2010).

10. P.P. Seth et al., J. Med. Chem. 52 (1), 10–13 (2009).

11. A.A. Levin, R. Zu, and R.S. Geary, "Basic Principles of the Pharmacokinetics of Antisense Oligonucleotide Drugs," in Antisense Drug Technology: Principles, Strategies, and Applications, S.T. Crooke, Ed. (CRC Press, Boca Raton, 2007), pp. 183–215.

12. B. Monia et al. J. Biol. Chem. 268 (19), 14514–14522 (1993).

13. R.S. Geary, R. Zu, and A.A. Levin, "Pharmacokinetic/Pharmacodynamic Properties of Phosphorothioate 2'-O-(2-Methoxyethyl)-Modified Antisense Oligonucleotides in Animals and Man," in Antisense Drug Technology: Principles, Strategies, and Applications, S.T. Crooke, Ed. (CRC Press, Boca Raton, 2007), pp. 306–326.

14. S.C. Semple et al., Nature Biotech. 28 (2), 172–176 (2010).

15. S.V. Dongen et al., Nature Methods 5 (12) 1023–1025 (2008).



blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lundbeck CEO Resigns Due to Code of Conduct Breach
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Janssen Partners with Transposagen Biopharmaceuticals for CAR-T Therapies
November 24, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here